# Treatment of Asymptomatic Toxocariasis With Albendazole in Children

> **NCT00755560** · PHASE3 · UNKNOWN · sponsor: **Hospital de Niños R. Gutierrez de Buenos Aires** · enrollment: 45 (actual)

## Conditions studied

- Toxocariasis

## Interventions

- **DRUG:** Albendazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00755560
- **Lead sponsor:** Hospital de Niños R. Gutierrez de Buenos Aires
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2015-07
- **Final completion:** 2025-07
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00755560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00755560, "Treatment of Asymptomatic Toxocariasis With Albendazole in Children". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00755560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
